Marshall Wace, LLP Gsk PLC Transaction History

Marshall Wace, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $93.7 Million - $106 Million	-2,228,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $89.7 Million - $106 Million	2,228,500 New	2,228,500 $97.1 Million
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $1.93 Million - $2.25 Million	-56,192 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $13.3 Million - $15.6 Million	-389,860 Reduced 87.4%	56,192 $2.07 Million
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $15.1 Million - $17 Million	396,406 Added 798.47%	446,052 $16.8 Million
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $1.88 Million - $2.16 Million	49,646 New	49,646 $2.03 Million
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $3.72 Million - $4.28 Million	-88,610 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.46 - $43.52 $3.59 Million - $3.86 Million	88,610 New	88,610 $3.78 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $44,285 - $47,994	-1,124 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $42,487 - $47,983	1,124 New	1,124 $43,000
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $230,611 - $255,916	-6,374 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $1.29 Million - $1.53 Million	-36,548 Reduced 85.15%	6,374 $226,000
Q3 2017 Nov 13, 2017	BUY	$39.44 - $41.55 $1.69 Million - $1.78 Million	42,922	42,922 $1.76 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.